OUTSOURCING OF DRUG TRIALS RAISES CONCERNS

Today’s NY Times discusses the good and the potentially bad when it comes to conducting trials of new drugs outside of the United States.   Subjects in developing countries may be rushing to sign up and disregarding their own safety.  Populations in some other countries may be so physically different from Americans that results of testing may not apply to us.  And some testing is done in Canada and Sweden, with populations similar to Americans physically, and financially.